IMPL
Impel Neuropharma Inc
Price:  
0.24 
USD
Volume:  
858,521.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IMPL Relative Valuation

-125577.7%
Upside

As of 2025-07-03, the Relative Valuation of Impel Neuropharma Inc (IMPL) is (302.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Impel Neuropharma Inc based on Relative Valuation is -125577.7%.

The range of the Relative Valuation is (296.98) - (421.69) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 12.9x - 18.3x 12.9x
Forward P/E multiples 12.5x - 20.7x 13.3x
Fair Price (296.98) - (421.69) (302.53)
Upside -123278.9% - -175002.5% -125577.7%
0.24 USD
Stock Price
(302.53) USD
Fair Price

IMPL Relative Valuation - Historical P/E Data

Date P/E